Acquired haemophilia: experience of two Italian centres with 17 new cases

被引:26
作者
DiBona, E
Schiavoni, M
Castaman, G
Ciavarella, N
Rodeghiero, F
机构
[1] SAN BORTOLO HOSP,DEPT HEMATOL,HEMOPHILIA & THROMBOSIS CTR,I-36100 VICENZA,ITALY
[2] POLICLIN,COAGULAT LAB,BARI,ITALY
[3] POLICLIN,HEMOPHILIA CTR,BARI,ITALY
关键词
acquired haemophilia; factor VIII inhibitor; factor VIII; immunosuppressive therapy; porcine factor VIII concentrate;
D O I
10.1046/j.1365-2516.1997.00102.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acquired haemophilia is a rare bur often catastrophic haemorrhagic disorder associated with a high mortality rate. No single therapeutic approach has been consistently successful and clinical experience remains mainly anecdotal. This report describes 17 new cases diagnosed at two Italian haemophilia centres between 1979 and 1995. There was no difference in sex distribution. Mean age at diagnosis was 50 years. Fifty-nine per cent of cases had associated disorders and 29% developed an inhibitor post partum. Eleven (64%) patients required substitutive therapy. Desmopressin was successfully used in five cases for minor bleeding. Immunosuppressive drugs (steroid, cyclophosphamide or experimental therapy) were used in 14 (82%) cases. Eight of 15 (52%) evaluable cases achieved complete remission (four post-partum). Fatal haemorrhage occurred in 2/15 (13%) of patients within 2 days from diagnosis. Acquired haemophilia is a severe coagulopathy. Prompt diagnosis with characterization and intensive treatment is usually required. However, particular subsets of patients such as those with inhibitor occurring post-partum or with low inhibitor titre at diagnosis usually show a more favourable clinical outcome.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 24 条
[1]   NATURAL ANTIBODIES TO FACTOR-VIII (ANTI-HEMOPHILIC FACTOR) IN HEALTHY-INDIVIDUALS [J].
ALGIMAN, M ;
DIETRICH, G ;
NYDEGGER, UE ;
BOIELDIEU, D ;
SULTAN, Y ;
KAZATCHKINE, MD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3795-3799
[2]  
CARRERAS LO, 1988, THROMB HAEMOSTASIS, V60, P343
[3]   A MONOCLONAL ANTIIDIOTYPIC ANTIBODY AGAINST THE ANTIGEN-COMBINING SITE OF ANTI-FACTOR-VIII AUTOANTIBODIES DEFINES AN IDIOTOPE THAT IS RECOGNIZED BY NORMAL HUMAN POLYSPECIFIC IMMUNOGLOBULINS FOR THERAPEUTIC USE (IVIG) [J].
DIETRICH, G ;
PEREIRA, P ;
ALGIMAN, M ;
SULTAN, Y ;
KAZATCHKINE, MD .
JOURNAL OF AUTOIMMUNITY, 1990, 3 (05) :547-557
[4]  
DIETRICH G, 1992, BLOOD, V79, P246
[5]   EFFECT OF ALUMINUM TRIS-O-ETHYL PHOSPHONATE (TEPA) ON LYCOPERSICUM ESCULENTUM MILL LEAVES INFECTED WITH PHYTOPHTHORA-CAPSICI LEON - CYTOLOGICAL AND CYTOCHEMICAL STUDY [J].
DURAND, MC ;
SALLE, G .
AGRONOMIE, 1981, 1 (09) :723-732
[6]   CYTOTOXIC SUPPRESSION OF ACQUIRED FACTOR-VIII-C INHIBITORS [J].
GREEN, D .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S14-S19
[7]  
GREEN D, 1993, THROMB HAEMOSTASIS, V70, P753
[8]  
GRINGERI A, 1991, THROMB HAEMOSTASIS, V65, P245
[9]  
HART HC, 1988, TRANSPLANT P, V20, P323
[10]  
HAUSER I, 1994, THROMB HAEMOSTASIS, V73, P1